两家公司宣布,合并后的公司更名为“tras Pharma, Inc.”,由新任首席执行官Werner Cautreels领导,将于周三在纳斯达克上市交易,股票代码为“TRAW”。
TRAW即将到来的里程碑包括在2024年下半年开始...查看全文
$Onconova Therapeutics, Inc.(ONTX)$ 8-K - Current report Filed: 2018-03-08 AccNo: 0001104659-18-015927 Size: 57 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ 8-K - Current report Filed: 2018-03-08 AccNo: 0001104659-18-015736 Size: 150 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ DEF 14A - Other definitive proxy statements Filed: 2018-02-28 AccNo: 0001047469-18-001129 Size: 399 KB 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2018-02-26 AccNo: 0001104659-18-012196 Size: 39 KB 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-20 AccNo: 0000919574-18-001944 Size: 110 KB 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2018-02-16 AccNo: 0001013594-18-000159 Size: 83 KB 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ PRE 14A - Other preliminary proxy statements Filed: 2018-02-16 AccNo: 0001047469-18-000858 Size: 397 KB 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2018-02-16 AccNo: 0001013594-18-000157 Size: 83 KB 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-14 AccNo: 0000905718-18-000218 Size: 36 KB 网页链接
$Onconova Therapeutics, Inc.(ONTX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-14 AccNo: 0000905718-18-000218 Size: 36 KB 网页链接